Reversible posterior encephalopathy syndrome associated with bortezomib.


Reversible posterior encephalopathy (RPES) is an uncommon neurological syndrome that is being increasingly reported in association with anti-neoplastic therapies. The first case of reversible posterior encephalopathy associated with the proteosome inhibitor bortezomib is described and the reported experience of the occurrence of RPES with other… (More)
DOI: 10.1111/j.1445-5994.2009.02097.x

1 Figure or Table


  • Presentations referencing similar topics